Routes to diagnosis for cancer - determining the patient journey using multiple routine data sets

被引:421
作者
Elliss-Brookes, L. [2 ,3 ,4 ]
McPhail, S. [1 ]
Ives, A. [5 ]
Greenslade, M. [5 ]
Shelton, J. [1 ]
Hiom, S. [6 ]
Richards, M. [7 ]
机构
[1] Natl Canc Intelligence Network, London SW1E 5RS, England
[2] Avon Canc Serv, Bristol BS1 3NX, Avon, England
[3] Somerset Canc Serv, Bristol BS1 3NX, Avon, England
[4] Wiltshire Canc Serv, Bristol BS1 3NX, Avon, England
[5] SW Publ Hlth Observ, Bristol BS8 2RA, Avon, England
[6] Canc Res UK, London EC1V 4AD, England
[7] Natl Canc Act Team, London SW1E 5RS, England
关键词
diagnosis; pathways; referral; survival; emergency; route; SURVIVAL; ENGLAND; PROSTATE; NORWAY; SWEDEN; LUNG;
D O I
10.1038/bjc.2012.408
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Cancer survival in England is lower than the European average, which has been at least partly attributed to later stage at diagnosis in English patients. There are substantial regional and demographic variations in cancer survival across England. The majority of patients are diagnosed following symptomatic or incidental presentation. This study defines a methodology by which the route the patient follows to the point of diagnosis can be categorised to examine demographic, organisational, service and personal reasons for delayed diagnosis. METHODS: Administrative Hospital Episode Statistics data are linked with Cancer Waiting Times data, data from the cancer screening programmes and cancer registration data. Using these data sets, every case of cancer registered in England, which was diagnosed in 2006-2008, is categorised into one of eight 'Routes to Diagnosis'. RESULTS: Different cancer types show substantial differences between the proportion of cases that present by each route, in reasonable agreement with previous clinical studies. Patients presenting via Emergency routes have substantially lower 1-year relative survival. CONCLUSION: Linked cancer registration and administrative data can be used to robustly categorise the route to a cancer diagnosis for all patients. These categories can be used to enhance understanding of and explore possible reasons for delayed diagnosis. British Journal of Cancer (2012) 107, 1220-1226. doi:10.1038/bjc.2012.408 www.bjcancer.com Published online 20 September 2012 (C) 2012 Cancer Research UK
引用
收藏
页码:1220 / 1226
页数:7
相关论文
共 29 条
[1]   What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable? [J].
Abdel-Rahman, M. ;
Stockton, D. ;
Rachet, B. ;
Hakulinen, T. ;
Coleman, M. P. .
BRITISH JOURNAL OF CANCER, 2009, 101 :S115-S124
[2]  
Association of Breast Surgery, 2011, AUD SCREEN DET CANC
[3]   Pathways to the diagnosis of prostate cancer in a British city. A population-based study [J].
Barrett, J ;
Hamilton, W .
SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2005, 39 (04) :267-270
[4]   Pathways to the diagnosis of lung cancer in the UK: a cohort study [J].
Barrett, Jacqueline ;
Hamilton, William .
BMC FAMILY PRACTICE, 2008, 9 (1)
[5]   The impact of the two-week wait rule on the diagnosis and management of bladder cancer in a single UK institution [J].
Blick, Christopher ;
Bailey, David ;
Haldar, Neil ;
Bdesha, Amarjit ;
Kelleher, John ;
Muneer, Asif .
ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2010, 92 (01) :46-50
[6]   Patients with previous cancer should not be excluded in international comparative cancer survival studies [J].
Brenner, Hermann ;
Hakulinen, Timo .
INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (10) :2274-2278
[7]  
*CANC RES UK CANC, 2006, STREL COMP PROGR VER
[8]  
Carter K., 2009, Open Color. Cancer J, V2, P27, DOI [10.2174/1876820200902010027, DOI 10.2174/1876820200902010027]
[9]   The waiting time paradox: population based retrospective study of treatment delay and survival of women with endometrial cancer in Scotland [J].
Crawford, SC ;
Davis, JA ;
Siddiqui, NA ;
de Caestecker, L ;
Gillis, CR ;
Hole, D .
BRITISH MEDICAL JOURNAL, 2002, 325 (7357) :196-196
[10]  
Department of Health, 2011, IMPR OUTC STRAT CANC